🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
1.730
+0.010 (0.58%)
At close: Nov 18, 2026, 4:00 PM EST
1.725
-0.005 (-0.29%)
After-hours: Nov 18, 2026, 5:22 PM EST

Grace Therapeutics Statistics

Total Valuation

GRCE has a market cap or net worth of $36.39 million. The enterprise value is $15.08 million.

Market Cap36.39M
Enterprise Value 15.08M

Important Dates

The last earnings date was Thursday, November 12, 2026, before market open.

Earnings Date Nov 12, 2026
Ex-Dividend Date n/a

Share Statistics

GRCE has 21.04 million shares outstanding. The number of shares has increased by 25.20% in one year.

Current Share Class 21.04M
Shares Outstanding 21.04M
Shares Change (YoY) +25.20%
Shares Change (QoQ) +16.48%
Owned by Insiders (%) 16.67%
Owned by Institutions (%) 22.90%
Float 13.27M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.66
P/TBV Ratio 1.84
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 13.61, with zero debt.

Current Ratio 13.61
Quick Ratio 13.22
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -36.20% and return on invested capital (ROIC) is -10.71%.

Return on Equity (ROE) -36.20%
Return on Assets (ROA) -10.19%
Return on Invested Capital (ROIC) -10.71%
Return on Capital Employed (ROCE) -18.07%
Weighted Average Cost of Capital (WACC) 6.48%
Revenue Per Employee n/a
Profits Per Employee -$4.28M
Employee Count5
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -1.71M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -42.33% in the last 52 weeks. The beta is 0.41, so GRCE's price volatility has been lower than the market average.

Beta (5Y) 0.41
52-Week Price Change -42.33%
50-Day Moving Average 1.99
200-Day Moving Average 2.70
Relative Strength Index (RSI) 36.16
Average Volume (20 Days) 110,347

Short Selling Information

The latest short interest is 1.67 million, so 7.93% of the outstanding shares have been sold short.

Short Interest 1.67M
Short Previous Month 1.68M
Short % of Shares Out 7.93%
Short % of Float 12.56%
Short Ratio (days to cover) 14.05

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -10.13M
Pretax Income -23.12M
Net Income -21.41M
EBITDA -10.13M
EBIT -10.13M
Earnings Per Share (EPS) -$1.20
Full Income Statement

Balance Sheet

The company has $21.31 million in cash and no debt, with a net cash position of $21.31 million or $1.01 per share.

Cash & Cash Equivalents 21.31M
Total Debt n/a
Net Cash 21.31M
Net Cash Per Share $1.01
Equity (Book Value) 55.48M
Book Value Per Share 2.64
Working Capital 20.35M
Full Balance Sheet

Cash Flow

Operating Cash Flow -8.93M
Capital Expenditures n/a
Depreciation & Amortization 8,000
Net Borrowing n/a
Free Cash Flow -8.93M
FCF Per Share -$0.42
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GRCE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -25.20%
Shareholder Yield -25.20%
Earnings Yield -69.15%
FCF Yield -24.54%

Analyst Forecast

The average price target for GRCE is $5.85, which is 238.27% higher than the current price. The consensus rating is "Strong Buy".

Price Target $5.85
Price Target Difference 238.27%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on July 10, 2023. It was a reverse split with a ratio of 1:6.

Last Split Date Jul 10, 2023
Split Type Reverse
Split Ratio 1:6

Scores

Altman Z-Score n/a
Piotroski F-Score 1